The second group is trophoblast cell surface antigen-2 (Trop-2), a transmembrane calcium signal transducer overly expressed in many epithelial cancers and believed to be correlated with disease progression and the development of metastases, including prostate cancer [10]. Here, TACSTD2 is linked to prostate carcinoma.